To link to post: http://bit.ly/VEU0B
Julie Zawisza, Director of Communications for the FDA’s center for Drug Evaluation and Research, discusses the FDA’s communications enhancement, reputation management and transparency.
Some of Julie’s VlogViews:
“What the agency does well is generate information. If nothing else, we’re a scientific agency that generates scientific data. It’s not hard to put that information out. What is more difficult and challenging is to provide context and meaning to it.”
The FDA’s Guide for Presenting Risk Information in Prescription Drug and Medical Device Promotion
The ExL Pharma Communications Conference Series:
Julie Zawisza, FDA
Sally Susman, Pfizer
John Bell, Ogilvy
Eric Obenzinger, Google
Tags: Communications, FDA, Julie Zawisza
